Form4insider filings, from the source

SEC Form 4 · accession 0001140361-15-001808

Adverum Biotechnologies, Inc. · ADVM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Thomas W. Chalberg
Officer — Chief Executive Officer · Director
Period of report
Dec 12, 2014
Accepted (ET)
Jan 14, 2015 · 5:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501756

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockDec 12, 2014M413$0.21A371,401D
Common StockDec 12, 2014G413$0.00D370,988D
Common StockF2Dec 12, 2014G413$0.00A413ISee Footnote
Common StockF3holding———420,000ISee Footnote
Common StockF4holding———420,000ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F5$0.21Dec 12, 2014M413D—Feb 23, 2022Common Stock413159,587D

Explanation of responses